All sites C00-96,D32-33,D42-43,D45-47,D76 458 89.2 1.9 3.5 0.9 4.5
Mouth, pharynx C00-14 6 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 98 78.5 1.0 9.4 1.8 9.2
  Oesophagus C15 1 100.0 - - - -
  Stomach C16 9 91.1 - - - 8.9
  Small intestine C17 3 100.0 - - - -
  Colon C18 33 91.5 0.6 4.8 0.6 2.4
  Rectum, rectosigmoid C19-20 16 98.8 - - 1.3 -
  Anus C21 1 100.0 - - - -
  Liver C22 5 66.7 4.2 20.8 - 8.3
  Gallbladder, bile ducts C23-24 5 47.8 4.3 8.7 8.7 30.4
  Pancreas C25 23 47.4 1.8 25.4 3.5 21.9
  Other digestive organs C26 2 50.0 - 16.7 8.3 25.0
Respiratory organs C30-39 28 68.3 8.6 10.8 1.4 10.8
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 27 69.2 8.3 10.5 1.5 10.5
  Mediastinum, pleura C38 0 - - 50.0 - 50.0
Bone C40-41 - - - - - -
Melanoma of the skin C43 17 100.0 - - - -
Skin, non-melanoma C44 23 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 137 99.0 0.3 - 0.1 0.6
Female genital organs C51-58 58 93.1 2.1 1.0 1.4 2.4
  Cervix uteri C53 8 97.4 - - - 2.6
  Corpus uteri C54 28 96.4 - - 1.4 2.2
  Uterus, other C55,C58 1 66.7 - - - 33.3
  Ovary C56 17 85.7 6.0 3.6 2.4 2.4
  Other female genital C51-52,C57 5 96.0 4.0 - - -
Urinary organs C64-68 20 92.0 - 4.0 - 4.0
  Kidney C64 11 90.9 - 3.6 - 5.5
  Bladder and urinary tract2 C65-68 9 93.3 - 4.4 - 2.2
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 15 84.4 - 5.2 - 10.4
Thyroid gland C73 9 97.8 2.2 - - -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 11 61.8 3.6 14.5 1.8 18.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 30 79.7 10.8 - 2.7 6.8
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 15 98.7 - - 1.3 -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 4 50.0 27.3 - 4.5 18.2
  Leukaemia C91-95 6 55.2 31.0 - 6.9 6.9
  Myelodysplastic syndromes D46 1 20.0 20.0 - - 60.0
  Myeloproliferaitive neoplasms D45,D47 1 80.0 - - - 20.0
Not included above
  Carcinoma in situ of the breast D05 12 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 34 100.0 - - - -
  Borderline tumour of the ovary D39 3 100.0 - - - -
  Basal cell carcinoma of the skin 122 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.